Characterizing Multimodal Mutational Processes in Cancer Using MOTET

Mutational signatures are characteristic patterns of somatic alterations in cancer genomes. A single aberrant mechanism can simultaneously generate coordinated patterns of alterations across multiple mutation modalities, including single-base substitutions (SBSs), doublet-base substitutions (DBSs), and small insertions and deletions (IDs). However, these signatures are typically inferred separately and linked post hoc, obscuring their shared underlying mechanisms. To resolve this, we formally define a Mutational Process (MP) as a unified latent activity that induces coupled mutational signatures across these modalities. We developed MOTET, a Bayesian framework that jointly infers multimodal MPs. Applied to 2,583 whole genomes from the PCAWG cohort, MOTET recovers known MPs more accurately than standard post hoc correlation methods. MOTET also identifies a process linking an SBS37-related signature with a TG>CA-dominated DBS component and resolves canonical SBS12-like activity into two separate MPs with distinct tissue distributions. These results establish a paradigm for formally defining catalogs of MPs and demonstrate that integrating across modalities enhances the ability to discover new mutational patterns.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.765471
Primary Topic
Cancer Genomics and Diagnostics
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Characterizing Multimodal Mutational Processes in Cancer Using MOTET

Tao Guo, Natasha Q. Gurevich, Jonathan H. Huggins, Joshua David Campbell et al.
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Genomics and Diagnostics
preprint

Characterizing Multimodal Mutational Processes in Cancer Using MOTET

Tao Guo, Natasha Q. Gurevich, Jonathan H. Huggins, Joshua David Campbell, Masanao Yajima, Jiaqi Sun, Kelly L. Geyer
preprint en

Abstract

Mutational signatures are characteristic patterns of somatic alterations in cancer genomes. A single aberrant mechanism can simultaneously generate coordinated patterns of alterations across multiple mutation modalities, including single-base substitutions (SBSs), doublet-base substitutions (DBSs), and small insertions and deletions (IDs). However, these signatures are typically inferred separately and linked post hoc, obscuring their shared underlying mechanisms. To resolve this, we formally define a Mutational Process (MP) as a unified latent activity that induces coupled mutational signatures across these modalities. We developed MOTET, a Bayesian framework that jointly infers multimodal MPs. Applied to 2,583 whole genomes from the PCAWG cohort, MOTET recovers known MPs more accurately than standard post hoc correlation methods. MOTET also identifies a process linking an SBS37-related signature with a TG>CA-dominated DBS component and resolves canonical SBS12-like activity into two separate MPs with distinct tissue distributions. These results establish a paradigm for formally defining catalogs of MPs and demonstrate that integrating across modalities enhances the ability to discover new mutational patterns.

bioRxiv (Cold Spring Harbor Laboratory)
Boston University (US), Brigham and Women's Hospital (US), Harvard University (US), University of Massachusetts Boston (US)
Instituto Tecnológico de Costa Rica, National Institutes of Health, National Cancer Institute
Cancer Genomics and Diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon